Sign In
Buy IBB
$167.50
+3.23 (+1.97%)
At Close: Jun 03, 2026
Why Biotech Sector ETF (IBB) May Turn Bullish In 2025
01:52pm, Tuesday, 10'th Dec 2024
One of the big themes we see emerging into 2025 is an expansion in Biotechnology and a bullish backdrop for certain biotechnology stocks.
iShares Biotechnology ETF: Playing Defense
01:33pm, Tuesday, 10'th Dec 2024
The biotech sector is very defensive and non-cyclical due to the necessity of medications and healthcare treatment being largely independent of economic growth and market risk sentiment. Money is retu
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Monday, 09'th Dec 2024
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Tuesday, 03'rd Dec 2024
Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05
Mizuho's Jared Holz on what Trump's FDA pick means for biotech innovation
06:44pm, Monday, 25'th Nov 2024
Mizuho's Jared Holz joins 'Fast Money' to talk what's next for biopharma space after president-elect Trump names his pick for FDA head.
Is Biotech's Bull Run Over? Examining Election Impacts
07:15am, Thursday, 21'st Nov 2024
The biotech sector recently experienced a sharp reversal following a failed breakout attempt post-election. While most areas of the market surged to new heights after Donald Trump's election win on No
Final Trade: Euro, IBB, SMH, NEM
06:21pm, Wednesday, 20'th Nov 2024
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral
07:36am, Monday, 14'th Oct 2024
I reiterate a hold rating on IBB due to its stretched valuation at nearly 20x earnings and mixed technical situation. Despite a 7% YTD gain, IBB has underperformed the S&P 500, which is up 21%, and sh
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Wednesday, 09'th Oct 2024
Making its debut on 02/05/2001, smart beta exchange traded fund iShares Biotechnology ETF (IBB) provides investors broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Tuesday, 01'st Oct 2024
If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund laun
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
11:11am, Monday, 23'rd Sep 2024
As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last Wednesday, several new opportunities and sector bull and bear markets might begi
Biotech Breakout: Stocks for Your Watchlist
07:35am, Thursday, 12'th Sep 2024
After a prolonged consolidation and downtrend following the pandemic-driven surge, the biotechnology sector is readying for a potential breakout and shifting its narrative. Represented by the iShares
3 ETFs for Growth Investors to Buy and Hold for Decades
04:57am, Sunday, 25'th Aug 2024
Exchange-traded funds aren't just for risk-averse investors. Many funds can give exposure to some great growth stocks.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
07:20am, Wednesday, 07'th Aug 2024
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
07:21am, Wednesday, 31'st Jul 2024
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund launched on 02/05/2001.
